Effects of Tezepelumab on Asthma Exacerbations and Type 2 Biomarkers in Patients with Severe, Uncontrolled Asthma with and Without Nasal Polyps: Results from a Post-Hoc Analysis of the Phase 2b PATHWAY Study

被引：0

作者：

Emson, C. ^{[1
]}

Corren, J. ^{[2
]}

Saapa, K. ^{[3
]}

Hellqvist, A. ^{[4
]}

Parnes, J. R. ^{[5
]}

Colice, G. ^{[6
]}

机构：

[1] AstraZeneca, TSEM PMDev, Gaithersburg, MD USA

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] AstraZeneca, Biometr, Warsaw, Poland

[4] AstraZeneca, Biometr, Gothenburg, Sweden

[5] Amgen Inc, Thousand Oaks, CA 91320 USA

[6] AstraZeneca, Gaithersburg, MD USA

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A4256

引用

页数：2